Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1125-1137
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1125
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1125
Table 3 Postoperative and surgical outcomes of patients with gastric cancer according albumin-bilirubin groups, n (%)
| Variables | Low-ALBI group (< -2.82), n = 211 | High-ALBI group (≥ -2.82), n = 150 | P value |
| Length of hospital stay (d) | 0.673 | ||
| Median (IQR) | 9 (6.0-13.3) | 10 (7.0-13.8) | |
| Postoperative complications (Clavien) | 0.029 | ||
| Non/minor POC (I-II) | 183 (86.7) | 117 (78) | |
| Major POC (III-IV) | 28 (13.3) | 33 (22) | |
| Postoperative chemotherapy | 0.917 | ||
| No | 117 (55.5) | 84 (56) | |
| Yes | 94 (44.5) | 66 (44) | |
| Chemotherapy-all (pre or postoperative) | 0.766 | ||
| No | 99 (46.9) | 68 (45.3) | |
| Yes | 112 (53.1) | 82 (54.7) | |
| 30-d motality | 0.023 | ||
| No | 206 (97.6) | 138 (92.6) | |
| Yes | 5 (2.4) | 11 (7.4) | |
| 90-d motality | 0.030 | ||
| No | 198 (94.7) | 130 (88.4) | |
| Yes | 11 (5.3) | 17 (11.6) | |
- Citation: Szor DJ, Pereira MA, Ramos MFKP, Tustumi F, Dias AR, Zilberstein B, Ribeiro Jr U. Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy. World J Gastrointest Surg 2023; 15(6): 1125-1137
- URL: https://www.wjgnet.com/1948-9366/full/v15/i6/1125.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i6.1125